Please provide your email address to receive an email when new articles are posted on . Robotic-assisted cystectomy demonstrated comparable 2-year PFS to open cystectomy among patients with bladder ...

In a randomized study, patients who underwent robotic-assisted and open radical cystectomy had similar 2-year progression survival rates. Robot-assisted radical cystectomy (RC) for invasive bladder ...

This transcript has been edited for clarity. Cheryl Lee, MD: Welcome to Medscape InDiscussion. I'm Cheryl Lee, and today we'll be discussing a topic that has continued to be controversial. I'm ...

How does robot-assisted radical cystectomy compare with traditional open radical cystectomy for management of patients with bladder cancer? To answer this question, the authors of a study published in ...

Please provide your email address to receive an email when new articles are posted on . Use of robot-assisted vs. open radical cystectomy led to a significantly increased number of days alive and out ...

Phase II study of gemcitabine, cisplatin, and sunitinib (S) in patients with advanced urothelial carcinoma (UC). Background: We reported our results on a prospective, randomized trial of open vs.

Robotic approach has similar oncologic efficacy, potential benefit in perioperative outcomes For patients with bladder cancer undergoing radical cystectomy, a robotic approach seems to have the same ...

Robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy resulted in a median of 82 vs 80 days alive and out of the hospital within 90 days of surgery. While ...

The impact of pathologic downstaging with neoadjuvant chemotherapy on survival of patients with muscle-invasive bladder cancer. A phase II, randomized study of nivolumab (nivo) or nivo plus BMS-986205 ...

Pruthi RS and Wallen EM (2008) Is robotic radical cystectomy an appropriate treatment for bladder cancer? Short-term oncologic and clinical follow-up in 50 consecutive patients. Urology 72: 617–620 ...

"The main strength of this study is the use of a nationwide population-based cohort encompassing nearly all patients with bladder cancer undergoing RC over 8 years, with detailed clinicopathological, ...